Citadel Advisors »

Merrimack Pharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $460k 34k 13.41
2023-09-30 $1.1M 85k 12.33
2023-06-30 $1.4M 115k 12.30
2023-03-31 $4.3M 353k 12.29
2022-12-31 $4.1M 354k 11.46
2022-06-30 $278k 28k 9.90
2022-03-31 $71k 11k 6.28
2021-09-30 $51k 11k 4.80
2021-06-30 $195k 31k 6.35
2021-03-31 $728k 116k 6.28
2020-12-31 $489k 71k 6.90
2020-09-30 $72k 18k 3.98
2020-06-30 $39k 12k 3.31
2020-03-31 $28k 13k 2.14
2019-12-31 $0 10k 0.00
2019-09-30 $110k 14k 8.06
2019-06-30 $109k 14k 8.06
2018-12-31 $66k 17k 3.86
2018-09-30 $194k 36k 5.34
2018-06-30 $365k 74k 4.90
2017-12-31 $120k 12k 10.22
2017-09-30 $183k 13k 14.58